Ecabet Sodium

CAS No. 86408-72-2

Ecabet Sodium( —— )

Catalog No. M16263 CAS No. 86408-72-2

Ecabet sodium: a potential new agent in the management of distal colitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 35 In Stock
50MG 51 In Stock
100MG 76 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ecabet Sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Ecabet sodium: a potential new agent in the management of distal colitis.
  • Description
    Ecabet sodium: a potential new agent in the management of distal colitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    86408-72-2
  • Formula Weight
    402.48
  • Molecular Formula
    C20H27NaO5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC(C)C1=C(C=C2C(=C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)C(=O)O)C)S(=O)(=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lawrance IC. J Gastroenterol Hepatol. 2010 Jul;25(7):1182-4.
molnova catalog
related products
  • Cinepazide maleate

    A cerebral vasodilator that acts as a calcium blocker; protect neuronal cells against OGD injury by suppressing OGD-induced oxidative stress and preserving mitochondrial functions.

  • CHMFL-KIT-033

    CHMFL-KIT-033 is a potent and selective inhibitor of the c-KIT T670I mutant (IC50: 0.045 μM) for gastrointestinal stromal tumors (GISTs).

  • β-CGRP, human TFA (1...

    β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and CRLR/RAMP2 cells.